Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention strategies.
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Desmond Tutu HIV Centre
International AIDS Society
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa
Clinical Care Options (CCO) expert audio: Dr. Colleen Kelley provides key insights on long-acting HIV pre-exposure prophylaxis strategies in late stages of development
Clinical Care Options (CCO) faculty Dr David Malebranche’s expert commentary on racial disparities in HIV care and strategies for improving patient engagement
Clinical Care Options’ (CCO) podcast with Drs. Daar and Swaminathan on key data following IAS 2021: CAB plus RPV, lenacapavir, islatravir, BPaL for MDR-TB
Download CCO slides reviewing clinically relevant new data reported at IAS 2021 on a wide range of ART management topics.